Yubo International Biotech Limited

符号: YBGJ

PNK

0.325

USD

今天的市场价格

-175.4014
市盈率
-1.8389
PEG比率
38.94M
MRK市值
0.00%
DIV收益率

Yubo International Biotech Limited (YBGJ) 财务报表

Q: 什么是 Yubo International Biotech Limited (YBGJ) 总资产是多少？

Yubo International Biotech Limited (YBGJ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Yubo International Biotech Limited (YBGJ). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Yubo International Biotech Limited 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003
balance-sheet.row.cash-and-short-term-investments	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.8
balance-sheet.row.short-term-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	0.3	0.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.inventory	0.3	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-current-assets	0.8	1.1	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.8
balance-sheet.row.property-plant-equipment-net	1.4	3.3	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-non-current-assets	1.6	3.5	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	2.3	4.6	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.8
balance-sheet.row.account-payables	0.5	0.3	0.1	0.3	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.2	0.3	0.4	0.4
balance-sheet.row.short-term-debt	0.4	0.8	0.3	1.3	1.2	0.9	0.8	0.7	0.6	0.5	0.4	0.3	0.2	0.2	0.1	0	0	0	0	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	0.4	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1.1	1.3	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3
balance-sheet.row.total-non-current-liabilities	0.4	1.9	0	1.6	1.5	1.3	1.2	1.1	1	0.9	0.8	0.7	0.6	0.5	0.4	0.3	0.2	0.3	0.4	0
balance-sheet.row.other-liabilities	0	0	0	-1.6	-1.5	-1.3	-1.2	-1.1	-1	-0.9	-0.8	-0.7	-0.6	-0.5	-0.4	-0.3	-0.2	-0.3	-0.4	0
balance-sheet.row.capital-lease-obligations	0.8	2.7	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	2.9	4.7	1.3	1.7	1.5	1.4	1.3	1.1	1	0.9	0.8	0.7	0.6	0.5	0.4	0.3	0.3	0.3	0.5	0.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1
balance-sheet.row.retained-earnings	-3.7	-2.5	-0.9	-29	-28.8	-28.7	-28.4	-28.3	-28.2	-28.1	-28	-27.9	-27.8	-27.7	-27.6	-27.5	-27.4	-27.3	-27.2	-27
balance-sheet.row.accumulated-other-comprehensive-income-loss	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	2.9	2.1	2	27.3	27.3	27.3	27.2	27.2	27.2	27.2	27.2	27.2	27.2	27.2	27.2	27.2	27.1	26.9	26.9	26.9
balance-sheet.row.total-stockholders-equity	-0.6	-0.1	1.2	-1.7	-1.5	-1.4	-1.3	-1.1	-1	-0.9	-0.8	-0.7	-0.6	-0.5	-0.4	-0.3	-0.2	-0.3	-0.2	0
balance-sheet.row.total-liabilities-and-stockholders-equity	2.3	4.6	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.8
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	0.8	2.7	0.3	1.3	1.2	0.9	0.8	0.7	0.6	0.5	0.4	0.3	0.2	0.2	0.1	0	0	0	0	0
balance-sheet.row.net-debt	0.8	2.7	-1.1	1.3	1.1	0.9	0.8	0.7	0.6	0.5	0.4	0.3	0.2	0.2	0.1	0	0	0	-0.3	-0.8

现金流量表

在 Yubo International Biotech Limited 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003
cash-flows.row.net-income	-1.2	-1.5	-0.7	-0.1	-0.1	-0.2	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-101	-0.2	-3
cash-flows.row.depreciation-and-amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	1.2	0.5	0.8	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0.1	-0.1	-0.2	0.1
cash-flows.row.account-receivables	0.1	-0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-0.2	-0.1	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.account-payables	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	1	0.6	0.8	-0.3	-0.2	-0.3	-0.2	-0.2	-0.2	-0.2	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0.1	-0.1	-0.2	0.1
cash-flows.row.other-non-cash-items	0	0	0	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.2	-0.1	100.9	-0.1	0.7
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	0	-0.6	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.acquisitions-net	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1
cash-flows.row.net-cash-used-for-investing-activites	0	-0.6	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1
cash-flows.row.debt-repayment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	0	0.1	0.6	0	0.1	0	0.1	0.1	0	0	0	0.1	0.1	0	0	0	-0.1	0	0	0
cash-flows.row.net-cash-used-provided-by-financing-activities	0	0.1	1.4	0	0.1	0	0.1	0.1	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0
cash-flows.row.effect-of-forex-changes-on-cash	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	0	-1.4	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.2	-0.5	-2.3
cash-flows.row.cash-at-end-of-period	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.8
cash-flows.row.cash-at-beginning-of-period	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.8	3.1
cash-flows.row.operating-cash-flow	0.1	-1	0.1	0	-0.1	-0.1	-0.1	-0.1	0	0	0	0	0	0	0	-0.1	-0.1	-0.2	-0.5	-2.3
cash-flows.row.capital-expenditure	0	-0.6	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.free-cash-flow	0	-1.6	0	0	-0.1	-0.1	-0.1	-0.1	0	0	0	0	0	0	0	-0.1	-0.1	-0.2	-0.5	-2.3

利润表行

Yubo International Biotech Limited 的收入与上期相比变化了 NaN%。据报告, YBGJ 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003
income-statement-row.row.total-revenue	0.1	1.2	1.4	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.cost-of-revenue	0.1	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit	0.1	0.8	1.2	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0.2	0.9	0.8	-0.1	-0.1	0	0	-0.1	-0.1	-0.1	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-101	-0.3	-4
income-statement-row.row.operating-expenses	1.3	2.4	2	0	-0.1	0.1	0.1	-0.1	-0.1	-0.1	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-101	-0.2	-3
income-statement-row.row.cost-and-expenses	1.3	2.8	2.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	102	0.2	3.1
income-statement-row.row.interest-income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	0	427	-0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	0	0	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0	0	0	0	0	0.1	0	0.1	71	0.2	-0.2
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0.2	0.9	0.8	-0.1	-0.1	0	0	-0.1	-0.1	-0.1	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-101	-0.3	-4
income-statement-row.row.total-operating-expenses	0	0	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0	0	0	0	0	0.1	0	0.1	71	0.2	-0.2
income-statement-row.row.interest-expense	0	427	-0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.depreciation-and-amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-1.2	-1.5	-0.7	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-101	-0.2	-3
income-statement-row.row.income-before-tax	-1.2	-1.5	-0.7	-0.1	-0.1	-0.2	-0.1	-0.1	-0.1	-0.1	0	0	0	0	0	0	0	-30	0	-3.2
income-statement-row.row.income-tax-expense	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0	0	0.1	71	0.2	-0.2
income-statement-row.row.net-income	-1.2	-1.5	-0.7	-0.1	-0.1	-0.2	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0	-0.1	-0.1	-101	-0.2	-3